Association of the C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene with schizophrenia: Association is significant in men but not in women

Abstract

Schizophrenia is a complex and common psychiatric disorder with a polygenic inheritance. In our previous report, we showed an association between the methylenetetrahydrofolate reductase (MTHFR) gene C677T and A1298C polymorphisms and schizophrenia in patients from Bakirkoy in Istanbul, Turkey [Sazci, A., Ergul, E., Guzelhan, Y., Kaya, G., Kara, I., 2003. Methylenetetrahydrofolate reductase gene polymorphisms in patients with schizophrenia. Mol. Brain Res. 117, 104–107]. We wanted also independently to confirm this study in a gender-specific manner with schizophrenic patients from Erenkoy in Istanbul, Turkey. To investigate the role of the C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene in schizophrenia in a gender-specific manner, we analyzed the genotypes of MTHFR677 and MTHFR1298 of 297 schizophrenic patients and 341 healthy controls, using a polymerase chain reaction restriction fragment length polymorphism method. The MTHFR 677T allele was significantly distributed ( χ 2 = 7.312; P = 0.026), between schizophrenic patients and healthy controls. The T677T genotype was overrepresented in the total schizophrenic patients (OR = 1.938; 95%CI = 1.133–3.315; χ 2 = 5.996; P = 0.014). Similarly, the T677T/A1298A compound genotype was the most significant one in the total schizophrenic patients (OR = 2.397; 95% CI = 1.327–4.330; χ 2 = 8.821; P = 0.003). The C1298C genotype was overrepresented in the total schizophrenic patients (OR = 1.706; 95%CI = 1.014–2.870; χ 2 = 4.126; P = 0.042). Likewise, the C677C/C1298C compound genotype was significant in the total schizophrenic patients (OR = 1.689; 95%CI = 0.985–2.894; χ 2 = 3.695; P = 0.055). When schizophrenic patients and healthy controls were stratified according to gender difference, the T677T genotype and T677T/A1298A compound genotype were significantly overrepresented (OR = 2.184; 95%CI = 1.069–4.462; χ 2 = 4.767; P = 0.029; OR = 2.748; 95%CI = 1.215–6.214; χ 2 = 6.301; P = 0.012, respectively) in men schizophrenic patients. However, neither the MTHFR C677T nor the A1298C polymorphisms are associated with schizophrenia in women. In conclusion, the MTHFR 677T allele and T677T, C1298C genotypes, and T677T/A1298A, C677C/C1298C compound genotypes are genetic risk factors for schizophrenia in men but not in women in a gender-specific manner.